Science
-
Corsa al supercomputer AI. In campo Eli Lilly con Nvidia
Eli Lilly collabora con Nvidia per costruire il supercomputer AI più potente del settore farmaceutico invezz – 28 ottobre 2025…
Leggi » -
AIFA approva la rimborsabilità della prima terapia genica CRISPR-CAS9
Sarà rimborsata dal Servizio sanitario nazionale (Ssn) la prima terapia genica con tecnologia CRISPR-CAS9 autorizzata in Italia e in Europa.…
Leggi » -
Nobel per la medicina a Victor Ambros e Gary Ruvkun per la scoperta del microRNA (miRNA)
Nobel per la Fisiologia o la Medicina 2024 a Victor Ambros e Gary Ruvkun A Victor Ambros e Gary Ruvkuni…
Leggi » -
Post Covid multifactorial inflammatory syndrome in children: the genetic cause
It affects children and adolescents two to six weeks after acute SARS-CoV-2 infection. Multisystem Inflammatory Syndrome…
Leggi » -
Produced the most complete human genome ever.
When it comes to sequencing the human genome, "complete" has always been a relative term. The first, deciphered 20 years…
Leggi » -
From the University of Camerino a gel to administer drugs to dysphagic patients
Gel formulations for oral administration of drugs, in particular to dysphagic patients UniCam – Technology transfer and management research area…
Leggi » -
The birth of scientific drug information: from its origins to the present day
The origins The origins of scientific information in ancient times are intertwined with the history of medicine and the history of…
Leggi » -
Covid vaccine, the Science study comparing Pfizer, Moderna and Johnson & Johnson protection in the USA
The data analysis has photographed a situation of substantially equal efficacy between the three compounds to prevent the infection of Sars…
Leggi » -
BioNtech's anticancer "vaccine" within 5 years
The immuno-oncologists who co-founded BioNTech, the company that developed…
Leggi » -
WHO celebrates Henrietta Lacks. The unknown who changed the world
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), welcomed the Lacks family for a meeting…
Leggi »